期刊文献+

心力衰竭患者血浆BNP的水平及其临床意义 被引量:7

下载PDF
导出
摘要 目的探讨血浆脑钠肽(BNP)在心力衰竭患者中的应用价值。方法选取2012年3月至2013年3月于我院心内科治疗的心力衰竭患者140例为观察组,同期随机选择年龄相仿的140例健康体检者为对照组,将观察组不同分级患者和对照组患者的血浆BNP水平进行检测比较。结果观察组BNP水平高于对照组,且NYHA分级高者高于分级低者(P<0.05),差异有统计学意义。结论可通过心力衰竭患者血浆BNP水平的增加来判断心力衰竭严重程度,血浆BNP水平检测心力衰竭具有临床意义。
出处 《中国医药指南》 2013年第30期477-478,共2页 Guide of China Medicine
  • 相关文献

参考文献7

二级参考文献57

  • 1黄培志,童朝阳,顾国嵘,顾剑勇,姚晨玲,姜燕飞,奚百顺,杨小亮,闵珉,李颖川.呼吸困难患者快速检测脑钠素的意义[J].上海医学,2005,28(1):61-63. 被引量:5
  • 2王岚峰,吴双,关秀茹,张蕾,沈景霞,薛凤华.脑钠素与急性心肌梗死预后关系的临床研究[J].中华心血管病杂志,2005,33(3):234-237. 被引量:66
  • 3孙晓鸥,姜朝晖,赵荣.B型利钠肽在急性呼吸困难鉴别诊断中的应用研究[J].中国实验诊断学,2005,9(2):263-265. 被引量:2
  • 4郑辉,李健雄,李卫凯.脑钠素用于慢性充血性心力衰竭的诊断研究[J].国际检验医学杂志,2006,27(5):473-474. 被引量:8
  • 5陈炼,朱伟达,楼丽娜,沈菁原,倪琦.BNP对判断心力衰竭严重程度及其预后的价值[J].苏州大学学报(医学版),2006,26(4):640-641. 被引量:17
  • 6Ishii J,Cui W, Kitagawa F, et al. Prognostic value of combination of cardiac tropnin T and B type natriuretic peptide after initiation of treatment in patients with chronic heart failure [J]. Clin Chem, 2003,49(12) :2020-2026.
  • 7Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure [J]. N Engl J Med, 2002,347(3) :161-167.
  • 8Cherico A, Delry S, Gianmessi D, et al. Measurement of cardiac natriuretic hormones ( atrial natriuretic peptide, brain natriuretic peptide,and related peptides) in clinical practise: the need for a new generation of immunoassay methods [J]. Clin Chem,2000,46 (10) :15-17.
  • 9Schinkel AF, Vourvouri EC, BaxJ J, et al. Relation between left ventricular contractile reserve during low dosed obutamine echo cardiography and plasma concentrations of natriuretie peptides [J]. Heart,2004,90(3) :293-296.
  • 10Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B brain natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J]. J Am Coil Cardiol,2002,39(2):202-209.

共引文献151

同被引文献55

  • 1陈尧飞.BNP对慢性心力衰竭患者心功能分级和预后判断价值分析[J].现代诊断与治疗,2012,23(12):2122-2123. 被引量:4
  • 2张鸿雁,刘同宝.心力衰竭患者血清C-反应蛋白变化及其临床意义[J].山东医药,2005,45(23):57-57. 被引量:5
  • 3张春玲,康金锁,陈曦,张丽,张健,杨跃进,丛祥凤.心血管病患者血浆N端B型脑钠肽水平变化及其临床意义[J].中华检验医学杂志,2006,29(1):31-34. 被引量:38
  • 4王文武,张真路.B型钠尿肽在心力衰竭分级及预后中的应用[J].微循环学杂志,2006,16(4):43-45. 被引量:13
  • 5Roger VL,Go AS,Lloyd-Jones DM,et al.Executive summary:heart disease and stroke statistics-2012 update:a report from the American Heart Associatian[J].Circulation, 2012,125 ( 1 ) : 188-197.
  • 6NDREPEPA G, BRAUN S, MEHILLI J, et al. Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute isehemia in patients with coronary artery disease [ J ]. Cardiology, 2008, 109 ( 4 ) : 249-257.
  • 7DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM) [ J]. Eur Heart J, 2008,29 ( 19 ) : 2388- 2442.
  • 8JUG B,SALOBIR BG,VENE N, et al. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure[J]. Heart Vessels,2009,24(4) :271-276.
  • 9NISSEN SE,TUZCU EM, SCHOENHAGEN P,et al. Statin therapy, LDL cholesterol, C-reactive protein and coronary artery disease [ J ]. N Engl J Med,2005,352 ( 1 ) :29-38.
  • 10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3643

引证文献7

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部